In the high fat fed/streptozotocin ICR (imprinting control region) mouse, a nongenetic model of type 2 diabetes, the inhibition of dipeptidyl peptidase IV improved glycemic control and increased β-cell function [10]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.